Spontaneous achilles tendon rupture in a patient with systemic lupus erythematosus due to ischemic necrosis after methyl prednisolone pulse therapy

Lupus

Volumn 14, Issue 4, 2005, Pages 321-325

  Chiou, Y M ^a   Lan, Joung Liang ^a,b,c   Hsieh, T Y ^a   Chen, Y H ^a   Chen, D Y ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Antiphospholipid antibodies; Hyperhomocysteinemia; MTP pulse therapy; Protein S deficiency; Systemic lupus erythematosus; Tendon rupture

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PROTEIN S;

ACHILLES TENDON RUPTURE; ADULT; ANGIOGRAPHY; ANTIBODY TITER; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; CASE REPORT; COLD SENSATION; CORTICOSTEROID THERAPY; DRUG PULSE THERAPY; ECHOGRAPHY; FEMALE; GANGRENE; HEEL; HEPARINIZATION; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INFLAMMATION; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; SYSTEMIC LUPUS ERYTHEMATOSUS; TIBIAL ARTERY;

ACHILLES TENDON; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; NECROSIS; POPLITEAL ARTERY; PROTEIN S DEFICIENCY; RUPTURE, SPONTANEOUS;

EID: 17644391112     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2046cr     Document Type: Article

References (13)

1. Pritchard CH, Berney S. Patellar tendon rupture in systemic lupus erythematosus. J Rheumatol 1989; 16: 786-788.
2. Furie RA, Chartash EK. Tendon rupture in systemic lupus erythematosus. Semin Arthritis Rheum 1988; 18: 127-133.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
4. Wysenbeek AJ, Leibovici L, Zoldan J. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1695-1696.
5. Staunton H, Stafford F, Leader M, O'Riordain D. Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol 2000; 57: 581-584.
6. Davies GE, Triplett DA. Corticosteroid-associated blue toe syndrome: role of anti-phospholipid antibodies. Ann Intern Med 1990; 113: 893-895.
7. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338; 1042-1050.
8. Long AA, Ginsberg JS, Brill-Edwards P et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66: 520-524.
9. Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic anti-phospholipid antibodies - a crucial role for acquired free protein S deficiency. Thromb Haemost 1996; 76: 190-194.
10. Cosgriff SW. Thromboembolic complication associated with ACTH and cortisone therapy. J Am Med Assoc 1951; 147: 924-926.
11. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994; 70: 863-870.
12. Özsoylu S, Strauss HS, Diamond LK. Effect of corticosteroid on coagulation of the blood. Nature 1962; 195: 1214-1215.
13. Özturk G, Özsoylu S, Gursel T Effect of methylprednisolone on F VIII: C and vWF levels. Ear J Haematol 1994; 53: 119-120.